C018 Mycophenolate mofetil prevents cyclosporine induced endothelial dysfunction in rat allograft aortic model - 17/04/09

Doi : 10.1016/S1875-2136(09)72205-3

C. Freguin ¹, R. Joannides ^1,³, N. Roux ^1,⁴, V. Richard ¹, D. Plissonnier ^1,⁴, C. Thuillez ^1,³, M. Godin ²
¹ Inserm U644, Rouen, France
² Nephrology, Rouen University Hospital, Bois Guillaume, France
³ Pharmacology, Rouen University Hospital, Rouen, France
⁴ Vascular surgery, Rouen University Hospital, Rouen, France

connectez-vous ou créez un compte

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Résumé

Systemic endothelial dysfunction and increased arterial sensitivity to vasoconstrictor agents are commonly observed after renal transplantation and appear partly related to the vascular toxicity of calcineurin inhibitors, that promote oxidative stress and decrease nitric oxide (NO) availability. We tested whether the inhibitor of inosine monophosphate deshydrogenase mycophenolate mofetil (MMF), an immunosuppressive agent with antioxidant properties, prevents the deleterious endothelial effects of cyclosporine A (CsA) in a rat allograft aortic model. Four groups of Lewis rats (n=7 per group), grafted with an aortic abdominal allograft from a Brown Norway donor, were fed for two weeks with either vehicle (control), CsA (5mg/kg/day), MMF (40mg/kg/day), or CsA+MMF. Arterial pressure was measured by tail cuff plethysmography. At day 15 after transplantation, endothelium-dependent (acetylcholine: Ach) and independent relaxations (sodium nitroprusside: SNP) were assessed in native thoracic aortic segments. Thoracic aortas were incubated with the NO-synthase inhibitor LNNA (10-5mol/L) to assess the contribution of NO in acetylcholine-induced relaxation. Moreover, the concentration of phenylephrine (Phe) providing the half-maximum vasoconstriction (EC50) was determined and 8-isoprostane plasma levels were measured (ELISA, n=3-5 per group). CsA impaired the relaxation to Ach compared with control and MMF alone. Combined treatment with MMF+CsA restored these relaxing responses (Figure 1). The relaxations to Ach were abolished by LNNA in all groups. There was no difference between groups for arterial pressure and the relaxation to SNP. Both MMF treated and control groups displayed similar dose response curves to Phe (Figure 2) whereas CsA treated group revealed significant decrease of EC50 (CsA :

1.0 0.1; control: 3.2 1.0; MMF: 2.7 1.3 and MMF+CsA: 2.9 1.0 10-7mol/L). 8-isoprostane levels were higher in CsA treated rats compared with other groups. Thus, our results demonstrate that MMF treatment combined with CsA prevents the native conduit artery endothelial dysfunction and suppresses the greater sensitivity to phenylephrine observed after CsA alone. These effects could result from the antioxidant properties of MMF and the related increase in NO availability.

Le texte complet de cet article est disponible en PDF.

Plan

Plan indisponible

Export

Vol 102 - N° S1

P. S33-S34 - mars 2009 Retour au numéro

Article précédent

C017 L’acide ascorbique et la tetrahydrobiopterine potentialisent le phénomène EDHF par génération de peroxyde d’hydrogène
A. Garry, D.-H. Edwards, T.-M. Griffith

| Article suivant

C019 Protéine C activ ée et glucocorticoïdes sont synergiques dans le choc septique expérimental
Y. Bouazza, N. Sennoun, C. Montemont, B. Levy

Bienvenue sur EM-consulte, la référence des professionnels de santé.

connectez-vous ou créez un compte

C018 Mycophenolate mofetil prevents cyclosporine induced endothelial dysfunction in rat allograft aortic model - 17/04/09

Résumé

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL